학술논문

A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond
Document Type
Article
Source
In: Cancer Medicine. (Cancer Medicine, November 2022, 11(22):4169-4181)
Subject
Language
English
ISSN
20457634